How to Develop Robust Solid Oral Dosage Forms: From Conception to Post-Approval: Expertise in Pharmaceutical Process Technology
Autor Bhavishya Mittalen Limba Engleză Paperback – 5 oct 2016
By merging the latest scientific information with practical instructions, this book provides pharmaceutical scientists in formulation research and development with a concrete look at the key aspects in the development of solid oral dosage forms.
- Focuses on important topics, such as robustness, bioavailability, formulation design, continuous processing, stability tests, modified release dosage forms, international guidelines, process scale-up, and much more
- Part of the Expertise in Pharmaceutical Process Technology series edited by Michael Levin
- Discusses common, real-world problems and offers both theoretical and practical solutions to these everyday issues
Preț: 305.28 lei
Preț vechi: 331.82 lei
-8% Nou
Puncte Express: 458
Preț estimativ în valută:
58.43€ • 60.22$ • 49.33£
58.43€ • 60.22$ • 49.33£
Carte tipărită la comandă
Livrare economică 22 februarie-08 martie
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780128047316
ISBN-10: 0128047313
Pagini: 190
Dimensiuni: 152 x 229 x 14 mm
Greutate: 0.32 kg
Editura: ELSEVIER SCIENCE
Seria Expertise in Pharmaceutical Process Technology
ISBN-10: 0128047313
Pagini: 190
Dimensiuni: 152 x 229 x 14 mm
Greutate: 0.32 kg
Editura: ELSEVIER SCIENCE
Seria Expertise in Pharmaceutical Process Technology
Cuprins
1. Rules of Drug Product Development2. Pharmacokinetics and Preformulation3. Formulation Development4. Pharmaceutical Unit Operations5. Process Development6. Analytical Considerations7. Process Scale-up, Tech-Transfer, and Optimization8. Business Acuity
Recenzii
"Readers will get a good overview of each topic, alongside practical advice and illustrative case studies. Decision trees and reference tables are particularly useful. ... This excellent book provides a great introduction for anyone starting a career in formulation science, and is a perfect starting point for trouble shooting issues throughout the formulation development process." --Emma McConnell, The Pharmaceutical Journal